CO

Corium

- NASDAQ:CORI
Last Updated 2024-04-23
  • Corium International is engaged in the development of advanced transdermal drug delivery technologies and products.

  • Locations

    • Menlo Park CA

  • Total Funding (USD)

    85.0 million

  • Acquisitions (2)

    • Corium International (2018)
    • StrataGent Life Sciences (2007)

  • Security

    Type: ORD
    CUSIP: 21887L107
    ISIN: US21887L1070
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo